Ligand Pharmaceuticals In shares owned by Standard Life Aberdeen
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Standard Life Aberdeen
from 13F filings
Historical chart of Standard Life Aberdeen investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Standard Life Aberdeen
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $34M | 190k | 177.14 |
| 2025-06-30 | $26M | 229k | 113.68 |
| 2025-03-31 | $23M | 216k | 105.14 |
| 2024-12-31 | $19M | 177k | 107.15 |
| 2024-09-30 | $25M | 249k | 100.09 |
| 2024-06-30 | $23M | 270k | 84.26 |
| 2024-03-31 | $21M | 282k | 73.10 |
| 2023-12-31 | $21M | 290k | 71.42 |
| 2023-09-30 | $19M | 320k | 59.92 |
| 2023-06-30 | $28M | 389k | 72.10 |
| 2023-03-31 | $21M | 282k | 73.56 |
| 2022-12-31 | $21M | 309k | 66.80 |
| 2022-09-30 | $38M | 442k | 86.13 |
| 2022-06-30 | $38M | 429k | 89.22 |
| 2022-03-31 | $38M | 335k | 112.30 |
| 2021-12-31 | $56M | 363k | 154.46 |
| 2021-09-30 | $50M | 358k | 139.45 |
| 2021-06-30 | $53M | 406k | 131.19 |
| 2021-03-31 | $27M | 175k | 152.45 |
| 2020-12-31 | $37M | 369k | 99.52 |
| 2020-09-30 | $19M | 197k | 95.32 |